Enliven Therapeutics (ELVN) Q3 2024 Earnings

Aug 13Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.55
-0.5
-0.46
-0.41

Details

Expected EPS
-0.55
Actual EPS
-0.41
Surprise EPS
0.14
Surprise Percent
+25.45%

Description

⁨Enliven Therapeutics⁩ (⁦ELVN⁩) has reported earnings of ⁦-0.41⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts